173 related articles for article (PubMed ID: 22793859)
1. Economic impact of human papillomavirus-associated head and neck cancers in the United States.
Coughlan D; Frick KD
Otolaryngol Clin North Am; 2012 Aug; 45(4):899-917. PubMed ID: 22793859
[TBL] [Abstract][Full Text] [Related]
2. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
3. Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma.
Wang XI; Thomas J; Zhang S
Ann Diagn Pathol; 2012 Jan; 16(1):7-12. PubMed ID: 22001331
[TBL] [Abstract][Full Text] [Related]
4. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
5. Five-year relative survival for human papillomavirus-associated cancer sites.
Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
[TBL] [Abstract][Full Text] [Related]
6. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.
Timbang MR; Sim MW; Bewley AF; Farwell DG; Mantravadi A; Moore MG
Hum Vaccin Immunother; 2019; 15(7-8):1920-1928. PubMed ID: 31050595
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers.
Gillison ML; Shah KV
Curr Opin Oncol; 2001 May; 13(3):183-8. PubMed ID: 11307062
[TBL] [Abstract][Full Text] [Related]
8. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
Sano D; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of human papillomavirus in oral cavity carcinomas.
Machado J; Reis PP; Zhang T; Simpson C; Xu W; Perez-Ordonez B; Goldstein DP; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S
Head Neck Oncol; 2010 Mar; 2():6. PubMed ID: 20226055
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
Mahal BA; Catalano PJ; Haddad RI; Hanna GJ; Kass JI; Schoenfeld JD; Tishler RB; Margalit DN
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1660-1667. PubMed ID: 31358520
[TBL] [Abstract][Full Text] [Related]
11. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
[TBL] [Abstract][Full Text] [Related]
12. Relationship of human papillomavirus with diseases of the oral cavity.
Boguñá N; Capdevila L; Jané-Salas E
Med Clin (Barc); 2019 Aug; 153(4):157-164. PubMed ID: 31109717
[TBL] [Abstract][Full Text] [Related]
13. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
[TBL] [Abstract][Full Text] [Related]
14. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
15. Health utilities lost and risk factors associated with HPV-induced diseases in men and women: the HPV Italian collaborative study group.
Marcellusi A; Capone A; Favato G; Mennini FS; Baio G; Haeussler K; Bononi M;
Clin Ther; 2015 Jan; 37(1):156-167.e4. PubMed ID: 25487083
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications.
Hennessey PT; Westra WH; Califano JA
J Dent Res; 2009 Apr; 88(4):300-6. PubMed ID: 19407148
[TBL] [Abstract][Full Text] [Related]
17. Beware of the dangers along the path towards the diagnosis of HPV-driven oropharyngeal squamous cell carcinoma.
Boscolo-Rizzo P; Bussu F
Acta Otorhinolaryngol Ital; 2017 Feb; 37(1):63-64. PubMed ID: 28374873
[No Abstract] [Full Text] [Related]
18. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus and Oropharyngeal Cancer.
Tanaka TI; Alawi F
Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective.
Aldalwg MAH; Brestovac B
Head Neck Pathol; 2017 Sep; 11(3):377-384. PubMed ID: 28176136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
